LEGN LEGEND BIOTECH CORP More: the full row for LEGEND BIOTECH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 610,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,576,295 shares; 2026Q2: 3,001,205 shares; 2026Q3: 9,154,389 shares 9,154,389 $182M 10.08% +6,153,184 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,064,207 shares; 2025Q1: 6,500,000 shares; 2025Q2: 6,100,729 shares; 2025Q3: 6,100,729 shares; 2025Q4: 5,943,180 shares; 2026Q1: 5,840,567 shares; 2026Q2: 5,322,908 shares; 2026Q3: 5,066,051 shares 5,066,051 $164M 9.09% -256,857 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,520,000 shares; 2025Q1: 8,520,000 shares; 2025Q2: 8,520,000 shares; 2025Q3: 8,520,000 shares; 2025Q4: 8,050,959 shares; 2026Q1: 8,050,959 shares; 2026Q2: 8,050,959 shares; 2026Q3: 8,150,959 shares 8,150,959 $153M 8.48% +100,000 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,336,796 shares; 2025Q1: 3,200,000 shares; 2025Q2: 3,071,588 shares; 2025Q3: 3,071,588 shares; 2025Q4: 2,922,335 shares; 2026Q1: 2,922,335 shares; 2026Q2: 2,922,335 shares; 2026Q3: 2,607,964 shares 2,607,964 $148M 8.22% -314,371 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,326,262 shares; 2025Q1: 4,700,000 shares; 2025Q2: 4,427,927 shares; 2025Q3: 4,427,927 shares; 2025Q4: 1,470,541 shares; 2026Q1: 2,341,652 shares; 2026Q2: 6,453,877 shares; 2026Q3: 6,148,000 shares 6,148,000 $127M 7.01% -305,877 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,105,000 shares; 2025Q1: 9,105,000 shares; 2025Q2: 8,492,557 shares; 2025Q3: 7,886,172 shares; 2025Q4: 6,165,223 shares; 2026Q1: 4,037,331 shares; 2026Q2: 3,667,097 shares; 2026Q3: 3,792,289 shares 3,792,289 $121M 6.72% +125,192 Timeline TVTX TRAVERE THERAPEUTICS INC More: the full row for TRAVERE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,802,750 shares; 2025Q1: 1,802,750 shares; 2025Q2: 1,540,691 shares; 2025Q3: 949,727 shares; 2025Q4: 517,884 shares; 2026Q1: 1,569,018 shares; 2026Q2: 2,000,000 shares; 2026Q3: 2,000,000 shares 2,000,000 $118M 6.52% 0 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 25,000 shares; 2025Q2: 656,573 shares; 2025Q3: 282,412 shares; 2025Q4: not reported; 2026Q1: 2,247,393 shares; 2026Q2: 2,434,207 shares; 2026Q3: 2,434,207 shares 2,434,207 $98.9M 5.48% 0 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,457,910 shares; 2025Q1: 2,400,000 shares; 2025Q2: 3,426,887 shares; 2025Q3: 4,027,800 shares; 2025Q4: 3,433,051 shares; 2026Q1: 3,398,224 shares; 2026Q2: 2,890,059 shares; 2026Q3: 3,000,000 shares 3,000,000 $96.9M 5.36% +109,941 Timeline BEAM BEAM THERAPEUTICS INC More: the full row for BEAM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,756,158 shares; 2025Q1: 2,518,170 shares; 2025Q2: 2,417,647 shares; 2025Q3: 2,517,647 shares; 2025Q4: 2,440,214 shares; 2026Q1: 3,682,185 shares; 2026Q2: 2,840,792 shares; 2026Q3: 3,933,894 shares 3,933,894 $96.2M 5.33% +1,093,102 Timeline CTMX CYTOMX THERAPEUTICS INC. More: the full row for CYTOMX THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,154,413 shares; 2025Q3: 3,646,503 shares; 2025Q4: 8,966,077 shares; 2026Q1: 15,013,093 shares; 2026Q2: 21,703,093 shares; 2026Q3: 21,140,726 shares 21,140,726 $57.5M 3.18% -562,367 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,000,000 shares; 2025Q4: 934,799 shares; 2026Q1: 934,799 shares; 2026Q2: 934,799 shares; 2026Q3: 934,799 shares 934,799 $54.8M 3.03% 0 Timeline SMMT SUMMIT THERAPEUTICS INC More: the full row for SUMMIT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,200,000 shares; 2026Q3: 3,000,000 shares 3,000,000 $50.7M 2.81% +1,800,000 Timeline RLAY RELAY THERAPEUTICS INC More: the full row for RELAY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 3,063,292 shares; 2025Q2: 2,887,014 shares; 2025Q3: 2,887,014 shares; 2025Q4: 1,424,259 shares; 2026Q1: 1,424,259 shares; 2026Q2: 3,300,000 shares; 2026Q3: 2,751,500 shares 2,751,500 $49.7M 2.75% -548,500 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,252,738 shares; 2025Q1: 2,338,629 shares; 2025Q2: 2,095,998 shares; 2025Q3: 2,302,172 shares; 2025Q4: 3,114,132 shares; 2026Q1: 3,114,132 shares; 2026Q2: 3,114,132 shares; 2026Q3: 3,114,132 shares 3,114,132 $47.8M 2.65% 0 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,225,576 shares; 2025Q1: 1,695,576 shares; 2025Q2: 976,267 shares; 2025Q3: 1,009,267 shares; 2025Q4: 856,462 shares; 2026Q1: 884,937 shares; 2026Q2: 1,375,000 shares; 2026Q3: 1,375,000 shares 1,375,000 $41.6M 2.31% 0 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 800,000 shares; 2025Q2: 1,173,605 shares; 2025Q3: 2,168,605 shares; 2025Q4: 1,970,357 shares; 2026Q1: 1,194,757 shares; 2026Q2: 1,194,757 shares; 2026Q3: 1,194,757 shares 1,194,757 $28.3M 1.57% 0 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 675,000 shares; 2025Q4: 640,395 shares; 2026Q1: 640,395 shares; 2026Q2: 661,795 shares; 2026Q3: 824,843 shares 824,843 $26.2M 1.45% +163,048 Timeline BNR BURNING ROCK BIOTECH LTD More: the full row for BURNING ROCK BIOTECH LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 994,883 shares; 2025Q1: 994,883 shares; 2025Q2: 994,883 shares; 2025Q3: 994,883 shares; 2025Q4: 994,883 shares; 2026Q1: 1,227,555 shares; 2026Q2: 1,238,563 shares; 2026Q3: 1,238,563 shares 1,238,563 $21.8M 1.21% 0 Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,085,368 shares; 2025Q1: 8,928,523 shares; 2025Q2: 8,463,742 shares; 2025Q3: 9,390,270 shares; 2025Q4: 9,366,526 shares; 2026Q1: 5,680,795 shares; 2026Q2: 2,522,660 shares; 2026Q3: 2,522,660 shares 2,522,660 $21M 1.16% 0 Timeline SRZN SURROZEN INC More: the full row for SURROZEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 486,252 shares 486,252 $15.6M 0.87% new Timeline STRO SUTRO BIOPHARMA INC More: the full row for SUTRO BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 479,590 shares; 2026Q1: 872,558 shares; 2026Q2: 872,558 shares; 2026Q3: 872,558 shares 872,558 $14.1M 0.78% 0 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 280,000 shares 280,000 $10.4M 0.58% new Timeline EVMN EVOMMUNE INC More: the full row for EVOMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 185,482 shares; 2026Q1: 625,496 shares; 2026Q2: not reported; 2026Q3: 1,200,000 shares 1,200,000 $9.91M 0.55% new Timeline PRLD PRELUDE THERAPEUTICS INC More: the full row for PRELUDE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 788,867 shares; 2026Q1: 1,592,551 shares; 2026Q2: 2,415,087 shares; 2026Q3: 2,311,955 shares 2,311,955 $9.04M 0.5% -103,132 Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,659,526 shares; 2025Q2: 3,456,318 shares; 2025Q3: 3,456,318 shares; 2025Q4: 3,456,318 shares; 2026Q1: 6,836,318 shares; 2026Q2: 6,836,318 shares; 2026Q3: 6,836,318 shares 6,836,318 $8.41M 0.47% 0 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000 $8.07M 0.45% 0 Timeline ALEC ALECTOR INC More: the full row for ALECTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 3,808,494 shares; 2026Q3: 4,308,494 shares 4,308,494 $7.97M 0.44% +500,000 Timeline AMRN AMARIN CORP PLC More: the full row for AMARIN CORP PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 576,111 shares; 2025Q3: 576,111 shares; 2025Q4: 389,273 shares; 2026Q1: 472,382 shares; 2026Q2: 532,982 shares; 2026Q3: 532,982 shares 532,982 $6.93M 0.38% 0 Timeline HROW HARROW INC More: the full row for HARROW INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 124,655 shares 124,655 $3.84M 0.21% new Timeline CRBU CARIBOU BIOSCIENCES INC More: the full row for CARIBOU BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,406,147 shares; 2025Q1: 3,269,147 shares; 2025Q2: 3,067,774 shares; 2025Q3: 3,067,774 shares; 2025Q4: 2,503,302 shares; 2026Q1: 2,503,302 shares; 2026Q2: 2,503,302 shares; 2026Q3: 2,503,302 shares 2,503,302 $3.18M 0.18% 0 Timeline PRQR PROQR THRAPEUTICS N V More: the full row for PROQR THRAPEUTICS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,750,000 shares; 2025Q1: 1,750,000 shares; 2025Q2: 1,649,462 shares; 2025Q3: 1,649,462 shares; 2025Q4: 1,566,317 shares; 2026Q1: 1,566,317 shares; 2026Q2: 1,566,317 shares; 2026Q3: 1,566,317 shares 1,566,317 $2.6M 0.14% 0 Timeline ENGN ENGENE THERAPEUTICS INC More: the full row for ENGENE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 457,855 shares; 2026Q3: 457,855 shares 457,855 $916K 0.05% 0 Timeline TRAW TRAWS PHARMA INC More: the full row for TRAWS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 84,400 shares; 2026Q3: 84,400 shares 84,400 $50.1K <0.01% 0 Timeline